PPARG and metabolic syndrome: Since PPARgamma is activated during obesity [39] and since it stimulates the renin gene expression [14, 18, 20], the intriguing possibility exists that the activated PPARgamma increases the renin production in MetS patients, thus acting prohypertensively.